about
Cardiac disease and Rett syndromeEffects of supratherapeutic doses of ebastine and terfenadine on the QT intervalEvaluation of differences in automated QT/QTc measurements between Fukuda Denshi and Nihon Koden systemsPharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation.Retrospective analysis of cisapride-induced QT changes in end-stage renal disease patients.The prevalence and significance of a short QT interval in 18,825 low-risk individuals including athletes.Assessment of QTc prolongation for non-cardiac-related drugs from a drug development perspective.Differences and similarities between chronic obstructive pulmonary disease and asthma.Effects of clinically relevant acute hypercapnic and metabolic acidosis on the cardiovascular system: an experimental porcine studyElectrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGsQT dynamics early after exercise as a predictor of mortality.Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.Lack of significant effect of bilastine administered at therapeutic and supratherapeutic doses and concomitantly with ketoconazole on ventricular repolarization: results of a thorough QT study (TQTS) with QT-concentration analysis.Individual QT-R-R relationship: average stability over time does not rule out an individual residual variability: implication for the assessment of drug effect on the QT interval.Cardiovascular safety of degarelix: results from a 12-month, comparative, randomized, open label, parallel group phase III trial in patients with prostate cancerContrasting time- and rate-based approaches for the assessment of drug-induced QT changes.Congenital long-QT syndromes: a clinical and genetic update from infancy through adulthood.Comparison of formulas for calculation of the corrected QT interval in infants and young childrenDesigning and interpreting the results of first-time-to-man studies.QTc prolongation assessment in anticancer drug development: clinical and methodological issuesRelation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT intervalNew quantitative methods for evaluation of dynamic changes in QT interval on 24 hour Holter ECG recordings: QT interval in idiopathic ventricular fibrillation and long QT syndrome.Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancerBaseline values from the electrocardiograms of children and adolescents with ADHDPrevalence and Risk Factors of Drug-Associated Corrected QT Prolongation in Elderly Hospitalized Patients: Results of a Retrospective Analysis of Data Obtained Over 6 Months.Psychotropic Drugs and Prolonged QTc Interval: Does it Really that Matter?Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice.QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular EleAssessment of QT(c)-prolonging potential of BX471 in healthy volunteers. A 'thorough QT study' following ICH E14 using various QT(c) correction methodsClinical characteristics, management, and control of permanent vs. nonpermanent atrial fibrillation: insights from the RealiseAF survey.Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells.Influence of high ovarian hormones on QT interval duration in young African womenPractical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder.Sex differences in cardiac autonomic regulation and in repolarisation electrocardiography.An overview of QT interval assessment in safety pharmacology.The measurement of the QT interval.Interaction between the cardiac rapidly (IKr) and slowly (IKs) activating delayed rectifier potassium channels revealed by low K+-induced hERG endocytic degradation.A Combined Linkage and Exome Sequencing Analysis for Electrocardiogram Parameters in the Erasmus Rucphen Family Study.Comparison of formulae for heart rate correction of QT interval in exercise electrocardiograms.QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability.
P2860
Q24675541-3837065F-6B14-4B67-B239-FDD1E1ECF91DQ28345558-C997A002-0513-4903-98AB-73F7A4E14D52Q28543030-879DA78E-D8F4-4A74-AB42-0DD315358BC1Q31026162-E53552B8-2712-4B77-B491-E185C739B2AEQ33145870-67DEC6A1-6E2F-4CBA-AD0B-B8C61E3E5B68Q33166270-33E42357-5F6A-41A8-BB39-E11AAF9ACEE6Q33590722-9C6D2158-544B-4731-9D21-0546D4D106BFQ33696756-5886FF70-3079-43B4-80C6-8A1B146498FFQ33752623-8AD02B9F-30E0-4D5F-9918-AA58BE7C4B15Q33883248-876CF694-6635-4D15-AD0C-4C565D2D3F62Q34046738-6B4AF251-10B7-43CE-A838-C8216DC25730Q34100661-984EB359-FA64-43B2-BE26-4F57E813ED56Q34189947-D0B11E6E-738B-4190-9B6F-3FEF99FA0202Q34412724-8D3B7849-CAC1-420B-94A7-5D7EFBB910E5Q34617904-B8317C6B-44C1-4C36-BE89-DF10DAD4B7C2Q34656447-5D1AD2C4-494C-4F92-A598-794CE57350F9Q34660661-81363035-3379-43CA-8E84-173171242931Q35235804-08FCBBF9-EBFF-4B03-9B55-C14B53510CCBQ35236261-C5A2B888-E325-47C0-A9BD-9B0D6939B61CQ35572883-B639628F-902E-4601-8AF8-5A49AEC3C0D5Q35579763-500E4E96-15BF-4FB2-8388-3A6E092CFFB3Q35771204-7E9750B8-B58F-4048-BA61-B39554A9885CQ36117284-6A57166C-8E5E-4498-9A87-D2C335182C60Q36326714-3A2DE9D6-C907-409B-A71A-C102E261AE2EQ36391603-9D2C1936-8077-4CD8-A8DA-3C036E026460Q36764542-BC57D0DD-D454-406E-A00C-21A815E680C0Q36987981-42FA2934-DD69-4F9A-BF40-603C27217340Q36998669-DC11E11E-1A24-463E-96C8-014164D83ABAQ37397815-4BB40C15-2D52-4CD2-835D-212CA61533ACQ37538004-29219D97-3B03-42D8-812E-24B2EEAFC98BQ37613893-B9676ECB-9E7F-4656-BF29-F12ECD7DE6EEQ37727902-380B98B2-03E0-409A-9A0D-E91A96F8B196Q37908140-E352C940-7794-4FBF-B42D-1447BA03A96FQ38081112-37886E0A-D336-4817-BB80-704561C65BC9Q38112653-CBEE6FD4-C4C1-4222-9F60-BB9CD659E581Q38211718-E56DABBD-65C4-4DB4-8343-2AC80574F0FCQ38621754-EB893209-58D9-4C8E-B34A-58EA1DE43668Q39161689-7044773A-EDC9-4C5E-BF0F-3BBDBEEBE83DQ39520130-983EC6E0-388B-4875-B4F4-2FA2A62558BBQ39602289-A77A9803-55FA-42AB-9E54-71E37B73D031
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Rate-corrected QT interval: techniques and limitations.
@en
type
label
Rate-corrected QT interval: techniques and limitations.
@en
prefLabel
Rate-corrected QT interval: techniques and limitations.
@en
P1476
Rate-corrected QT interval: techniques and limitations.
@en
P2093
P304
P356
10.1016/0002-9149(93)90035-B
P407
P577
1993-08-01T00:00:00Z